You are here: Home / API / Hot APIs / Baloxavir Marboxil(1985606-14-1)C27H23F2N3O7S

Baloxavir Marboxil(1985606-14-1)C27H23F2N3O7S

  • Chemical Name:Baloxavir marboxil
  • CAS No.:1985606-14-1
  • MF:C27H23F2N3O7S
  • MW:571.55
  • Purity:≥98% or according to customer requested
  • Product Categories API; Intermediates & Fine Chemicals; Pharmaceuticals
  • Test method: HPLC

What is Baloxavir marboxil?

Baloxavir Marboxil is an orally bioavailable prodrug and influenza cap-dependent endonuclease (CEN) inhibitor, with antiviral activity.  It is an antiviral drug developed by Shionogi Co., a Japanese pharmaceutical company and Roche for the treatment of influenza A and influenza B infections. The drug was initially approved for use in Japan in February 2018 and approved by the FDA on October 24, 2018, for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. Baloxavir marboxil, a cap-endonuclease inhibitor, has a unique mechanism of action when compared to the currently existing neuraminidase inhibitor drug class used to treat influenza infections. (Source: DrugBank)

Basic information   
Product Name: Baloxavir marboxil
Synonyms: XOFLUZA; Xofluza; aloxavir marboxil; Baloxavir marboxil; Baloxavir marboxil INN
CAS: 1985606-14-1
MF: C27H23F2N3O7S
MW: 571.55
Product Categories: API
Chemical Structure

Baloxavir marboxil            

Chemical Properties     
Boiling point  712.8±70.0 °C(Predicted)
density  1.57±0.1 g/cm3(Predicted)
storage temp.  Sealed in dry,Store in freezer, under -20°C
pka -1.46±0.40(Predicted)
Baloxavir marboxil Uses And Synthesis

Baloxavir marboxil is an influenza medication, an antiviral,that is taken as a single dose tablet,by mouth, by individuals that are 12 years of age or older,that have presented symptoms of this infection for no more than 48 hours.The efficacy of baloxavir marboxil administered after 48 hours has not been tested.

Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

MSDS: MSDS available.

COA: COA can be available if you send us inquiry.

Email us at: for more details.



Active Pharmaceutical Ingredients (APIs)& Pharma intermediates Supplier



Maxmedchem Corporation, was founded in 2004 and is the one of top manufacturers of Active Pharmaceutical Ingredients (APIs), and intermediates.


Add : 1901 S.Lynx Place, Ontario, CA 91761
Phone : +16263716327
Copyright © 2021 MAXMEDCHEM Co. Ltd. All rights reserved. | Sitemap